ERYTHROCIN Side Effects

5842024-3 | Feeling Abnormal, Gait Disturbance, Sunburn
on Aug 11, 2008 Female patient from UNITED STATES , 47 years of age, weighting 140.0 lb, was diagnosed with infection (What is infection?) and was treated with Erythrocin (View Usage). Patient experienced the following unwanted or unexpected effects: feeling abnormal, gait disturbance, sunburn. Erythrocin dosage: Average 3 Times A Day Po.

5807717-2 | Abdominal Mass, Abdominal Pain, Diverticulum Intestinal, Haematoma, Pyrexia
Patient was taking Erythrocin (View Usage). Patient had the following side effects: abdominal mass, abdominal pain (What is abdominal pain?), diverticulum intestinal, haematoma, pyrexia on Jan 10, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 79 years of age, weighting 108.0 lb, was diagnosed with pertussis, depression (What is depression?), pain (What is pain?), phlebitis and. Erythrocin dosage: . During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), PROPOFAN (View Propofan Review and Propofan Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), ACETORPHAN (View Acetorphan Review and Acetorphan Label ), ENDOTELON (View Endotelon Review and Endotelon Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), FOSAVANCE (View Fosavance Review and Fosavance Label ). Patient was hospitalized.

5374030-X | Hepatic Failure, Hepatic Function Abnormal
Adverse event was reported on Jun 20, 2007 by a Male patient taking Erythrocin (View Usage) (Dosage: ) was diagnosed with bronchitis (What is bronchitis?) and. Location: JAPAN , 50 years of age, After Erythrocin was administered, patient had the following side effects: hepatic failure, hepatic function abnormal. During the same period patient was treated with AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ), SODIUM ALGINATE (View Sodium Alginate Review and Sodium Alginate Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), BROMHEXINE HYDROCHLORIDE (View Bromhexine Hydrochloride Review and Bromhexine Hydrochloride Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ).

5261135-7 | Dizziness, Fall
on Mar 01, 2007 Male patient from UNITED KINGDOM , 66 years of age, weighting 154.3 lb, was diagnosed with lower respiratory tract infection, pain (What is pain?), cough and was treated with Erythrocin (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), fall (What is fall?). Erythrocin dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), PHOLCODINE (View Pholcodine Review and Pholcodine Label ).


5215424-2 | Hepatitis Fulminant
on Jan 12, 2007 Female patient from JAPAN , 78 years of age, was treated with Erythrocin (View Usage). Patient had the following side effects: hepatitis fulminant. Erythrocin dosage: . During the same period patient was treated with DOXAPRAM HYDROCHLORIDE HYDRATE (View Doxapram Hydrochloride Hydrate Review and Doxapram Hydrochloride Hydrate Label ), DORIPENEM HYDRATE (View Doripenem Hydrate Review and Doripenem Hydrate Label ).

5200495-X | Chest Discomfort, Chest Pain, Malaise
Patient was taking Erythrocin (View Usage). After Erythrocin was administered, patient had the following side effects: chest discomfort, chest pain (What is chest pain?), malaise on Dec 29, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 47 years of age, weighting 79.15 lb, was diagnosed with chronic obstructive pulmonary disease and. Erythrocin dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), MIGRALEVE (View Migraleve Review and Migraleve Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), VENTOLIN (View Ventolin Review and Ventolin Label ).

5116340-7 | Ageusia, Glossodynia, Tongue Ulceration
Adverse event was reported on Sep 19, 2006 by a Female patient taking Erythrocin (View Usage) (Dosage: ) was diagnosed with corneal cyst and. Location: UNITED KINGDOM , 62 years of age, Patient experienced the following unwanted or unexpected effects: ageusia, glossodynia, tongue ulceration. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (Dose- Ug) (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FLUPENTIXOL DIHYDROCHLORIDE (View Flupentixol Dihydrochloride Review and Flupentixol Dihydrochloride Label ), FUSIDIC ACID (Ocular Use) (View Fusidic Acid Review and Fusidic Acid Label ).

4811515-6 | Abdominal Pain, Anorexia, Arthralgia, Chromaturia, Faeces Pale, Fatigue, Hepatitis Cholestatic, Hepatomegaly, Liver Function Test Abnormal
on Oct 17, 2005 Female patient from UNITED KINGDOM , child 10 years of age, was diagnosed with respiratory tract infection and was treated with Erythrocin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anorexia, arthralgia, chromaturia, faeces pale, fatigue, hepatitis cholestatic, hepatomegaly, liver function test abnormal. Erythrocin dosage: . Patient was hospitalized.

4771534-5 | Multi-organ Failure, Pancreatitis Acute
on Feb 25, 2004 Male patient from JAPAN , 55 years of age, was diagnosed with nocardiosis, renal transplant and was treated with Erythrocin (View Usage). After Erythrocin was administered, patient had the following side effects: multi-organ failure, pancreatitis acute. Erythrocin dosage: . During the same period patient was treated with BACTA (View Bacta Review and Bacta Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

4754173-1 | Cardiac Failure, Hypothermia
Patient was taking Erythrocin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, hypothermia (What is hypothermia?) on Mar 30, 2005 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with infection prophylaxis and. Erythrocin dosage: . During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), LACTOBACILLUS SPOROGENES (View Lactobacillus Sporogenes Review and Lactobacillus Sporogenes Label ). Patient was hospitalized.

4754170-6 | Blood Albumin Decreased, Clostridium Colitis, Diarrhoea, Gastrointestinal Disorder, Multi-organ Failure, Sepsis, Thrombocytopenia
Adverse event was reported on Apr 25, 1996 by a Female patient taking Erythrocin (View Usage) (Dosage: ) was diagnosed with prophylaxis, diarrhoea and. Location: JAPAN , 76 years of age, Patient had the following side effects: blood albumin decreased, clostridium colitis, diarrhoea, gastrointestinal disorder, multi-organ failure, sepsis (What is sepsis?), thrombocytopenia. During the same period patient was treated with KANAMYCIN (View Kanamycin Review and Kanamycin Label ), CEFAMEZINE (Route Dr) (View Cefamezine Review and Cefamezine Label ), LOPERAMIDE HYDROCHLORIDE (View Loperamide Hydrochloride Review and Loperamide Hydrochloride Label ), SOLMEDROL (View Solmedrol Review and Solmedrol Label ), URINASTATIN (Route Dr) (View Urinastatin Review and Urinastatin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PENTOCILLIN (Route Dr) (View Pentocillin Review and Pentocillin Label ). Patient was hospitalized.

4754169-X | Anorexia, Anuria, Dyspnoea, Left Ventricular Failure, Renal Failure Acute, Respiratory Failure
on Jan 10, 2001 Male patient from JAPAN , 64 years of age, was diagnosed with pneumonia primary atypical, cardiac disorder, hyperuricaemia, hypertension, ventricular arrhythmia and was treated with Erythrocin (View Usage). After Erythrocin was administered, patient had the following side effects: anorexia, anuria, dyspnoea, left ventricular failure, renal failure acute, respiratory failure. Erythrocin dosage: . During the same period patient was treated with CEFOTAXIME SODIUM (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MANIDIPINE HYDROCHLORIDE (View Manidipine Hydrochloride Review and Manidipine Hydrochloride Label ), MEXILETINE HYDROCHLORIDE (View Mexiletine Hydrochloride Review and Mexiletine Hydrochloride Label ), ASPIRIN DIALUMINATE (View Aspirin-dialuminate Review and Aspirin-dialuminate Label ), TERAZOSIN HYDROCHLORIDE (View Terazosin Hydrochloride Review and Terazosin Hydrochloride Label ).

4754165-2 | Activities Of Daily Living Impaired, Carpal Tunnel Syndrome, Diabetic Neuropathy, Implant Site Effusion, Instillation Site Pain, Movement Disorder, Pain In Extremity, Paralysis
on Jul 09, 2001 Male patient from JAPAN , 50 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Erythrocin (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, carpal tunnel syndrome (What is carpal tunnel syndrome?), diabetic neuropathy, implant site effusion, instillation site pain, movement disorder (What is movement disorder?), pain in extremity, paralysis (What is paralysis?). Erythrocin dosage: . During the same period patient was treated with CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), TEMOCAPRIL HYDROCHLORIDE (View Temocapril Hydrochloride Review and Temocapril Hydrochloride Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), FERROUS CITRATE (View Ferrous Citrate Review and Ferrous Citrate Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), NICERITROL (View Niceritrol Review and Niceritrol Label ).

4754162-7 | Status Epilepticus
Patient was taking Erythrocin (View Usage). Patient had the following side effects: status epilepticus on Mar 07, 2002 from JAPAN Additional patient health information: Male patient , child 4 years of age, was diagnosed with bronchitis (What is bronchitis?) and. Erythrocin dosage: . During the same period patient was treated with THEOPHYLLINE (View Theophylline Review and Theophylline Label ). Patient was hospitalized.

4754158-5 | Cardiac Arrest, Haemoptysis
Adverse event was reported on May 28, 1984 by a Female patient taking Erythrocin (View Usage) (Dosage: ) was diagnosed with legionella infection, lung neoplasm malignant and. Location: JAPAN , 71 years of age, weighting 92.59 lb, After Erythrocin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), haemoptysis.

4754154-8 | Anaphylactic Shock, Chest Pain, Urticaria
on Sep 22, 2000 Female patient from JAPAN , 14 years of age, was diagnosed with antibiotic prophylaxis, pyrexia and was treated with Erythrocin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, chest pain (What is chest pain?), urticaria. Erythrocin dosage: . During the same period patient was treated with TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ), EXTRACT FROM INFLAMMATORY RABBIT SKIN INOCULATED BY VACCINIA VIRUS (View Extract From Inflammatory Rabbit Skin Inoculated By Vaccinia Virus Review and Extract From Inflammatory Rabbit Skin Inoculated By Vaccinia Virus Label ), FOSFOMYCIN (View Fosfomycin Review and Fosfomycin Label ), PIROMIDIC ACID (View Piromidic Acid Review and Piromidic Acid Label ), SERRAPEPTASE (View Serrapeptase Review and Serrapeptase Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ). Patient was hospitalized.

4754153-6 | Hypersensitivity, Lung Infiltration, Pulmonary Eosinophilia
on Mar 18, 1996 Female patient from JAPAN , 62 years of age, was diagnosed with bronchitis chronic, menopausal symptoms, rhinitis allergic, nasopharyngitis and was treated with Erythrocin (View Usage). Patient had the following side effects: hypersensitivity, lung infiltration, pulmonary eosinophilia. Erythrocin dosage: . During the same period patient was treated with ESTRIOL (View Estriol Review and Estriol Label ), MEQUITAZINE (View Mequitazine Review and Mequitazine Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

4754152-4 | Multi-organ Failure, Pancreatitis Acute, Respiratory Failure
Patient was taking Erythrocin (View Usage). After Erythrocin was administered, patient had the following side effects: multi-organ failure, pancreatitis acute, respiratory failure on Feb 25, 2004 from JAPAN Additional patient health information: Male patient , 55 years of age, was diagnosed with nocardiosis, renal transplant and. Erythrocin dosage: . During the same period patient was treated with BACTA (View Bacta Review and Bacta Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

4754150-0 | Erythema Multiforme, Intestinal Mucosal Hypertrophy
Adverse event was reported on Jun 15, 1999 by a Female patient taking Erythrocin (View Usage) (Dosage: ) was diagnosed with infection prophylaxis and. Location: JAPAN , child 3 years of age, Patient experienced the following unwanted or unexpected effects: erythema multiforme, intestinal mucosal hypertrophy. Patient was hospitalized.

4754149-4 | Dyspnoea, Laryngeal Oedema, Pharyngeal Oedema, Vomiting
on Jul 22, 1998 Male patient from JAPAN , 55 years of age, was diagnosed with asthma (What is asthma?), bronchitis (What is bronchitis?) and was treated with Erythrocin (View Usage). Patient had the following side effects: dyspnoea, laryngeal oedema, pharyngeal oedema, vomiting. Erythrocin dosage: . During the same period patient was treated with ONON (View Onon Review and Onon Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ). Patient was hospitalized.

4754147-0 | Rhabdomyolysis
on May 21, 2004 Female patient from JAPAN , 68 years of age, weighting 92.59 lb, was diagnosed with infection (What is infection?), disseminated intravascular coagulation, malnutrition, gastrointestinal disorder and was treated with Erythrocin (View Usage). After Erythrocin was administered, patient had the following side effects: rhabdomyolysis. Erythrocin dosage: . During the same period patient was treated with GABEXATE MESILATE (View Gabexate Mesilate Review and Gabexate Mesilate Label ), SUGAR/ELECTROLYTE/AMINO ACID/PREPARATIONS (View Sugar/electrolyte/amino Acid/preparations Review and Sugar/electrolyte/amino Acid/preparations Label ), MINOCYCLINE HYDROCHLORIDE (View Minocycline Hydrochloride Review and Minocycline Hydrochloride Label ), FOSFOMYCIN (View Fosfomycin Review and Fosfomycin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

4754146-9 | Aplastic Anaemia
Patient was taking Erythrocin (View Usage). Patient experienced the following unwanted or unexpected effects: aplastic anaemia on Jul 26, 1999 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with bronchiectasis, cough, dyspnoea and. Erythrocin dosage: . During the same period patient was treated with AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ), CARBOCISTEINE LYSINE (View Carbocisteine Lysine Review and Carbocisteine Lysine Label ). Patient was hospitalized.

4754145-7 | Bone Marrow Depression, Eosinophil Count Increased, Granulocytopenia, Hypersensitivity, Platelet Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jan 28, 2002 by a Female patient taking Erythrocin (View Usage) (Dosage: ) was diagnosed with pneumonia primary atypical, myocarditis, cardiac failure, gastric ulcer and. Location: JAPAN , 51 years of age, Patient had the following side effects: bone marrow depression, eosinophil count increased, granulocytopenia, hypersensitivity, platelet count decreased, white blood cell count decreased. During the same period patient was treated with PANIPENEM BETAMIPRON (View Panipenem-betamipron Review and Panipenem-betamipron Label ), PANIPENEM BETAMIPRON (View Panipenem-betamipron Review and Panipenem-betamipron Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

4754143-3 | Haemolytic Anaemia, Oxygen Saturation Decreased
on Sep 16, 1997 Male patient from JAPAN , child 0 years of age, was diagnosed with respiratory disorder, sputum retention, bronchospasm, rickettsiosis, prophylaxis, anaemia neonatal and was treated with Erythrocin (View Usage). After Erythrocin was administered, patient had the following side effects: haemolytic anaemia, oxygen saturation decreased. Erythrocin dosage: . During the same period patient was treated with AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ), SPUTUM EXCRETION (View Sputum Excretion Review and Sputum Excretion Label ), POTASSIUM PHOSPHATE DIBASIC (View Potassium Phosphate Dibasic Review and Potassium Phosphate Dibasic Label ), EPOETIN ALFA (View Epoetin Alfa Review and Epoetin Alfa Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ).

4754142-1 | Deafness, Otitis Media
on Oct 29, 1997 Female patient from JAPAN , 76 years of age, was diagnosed with pneumonia (What is pneumonia?), gastrointestinal haemorrhage and was treated with Erythrocin (View Usage). Patient experienced the following unwanted or unexpected effects: deafness, otitis media. Erythrocin dosage: . During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ).

4754141-X | Diarrhoea, Eczema, Platelet Count Decreased
Patient was taking Erythrocin (View Usage). Patient had the following side effects: diarrhoea, eczema (What is eczema?), platelet count decreased on Jan 01, 1997 from JAPAN Additional patient health information: Male patient , child 0 years of age, . Erythrocin dosage: . During the same period patient was treated with TERBUTALINE SULFATE (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), ALBUTEROL SULFATE HFA (View Albuterol Sulfate Hfa Review and Albuterol Sulfate Hfa Label ), CROMOLYN SODIUM (View Cromolyn Sodium Review and Cromolyn Sodium Label ). Patient was hospitalized.

4754140-8 | Anaphylactic Shock, Choking Sensation, Diarrhoea, Gait Disturbance
Adverse event was reported on Mar 31, 1997 by a Male patient taking Erythrocin (View Usage) (Dosage: ) was diagnosed with pharyngolaryngeal pain, cough and. Location: JAPAN , 65 years of age, After Erythrocin was administered, patient had the following side effects: anaphylactic shock, choking sensation, diarrhoea, gait disturbance. During the same period patient was treated with PRANOPROFEN (View Pranoprofen Review and Pranoprofen Label ), COUGHCODE N (View Coughcode-n Review and Coughcode-n Label ).

4661588-9 | Pericardial Effusion, Pleural Effusion
on Mar 22, 2005 Female patient from , child 6 years of age, weighting 35.27 lb, was diagnosed with respiratory failure, bronchiectasis, sputum retention, granuloma, glaucoma (What is glaucoma?) and was treated with Erythrocin (View Usage). Patient experienced the following unwanted or unexpected effects: pericardial effusion, pleural effusion. Erythrocin dosage: . During the same period patient was treated with MEPTIN (View Meptin Review and Meptin Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ), RIZABEN (View Rizaben Review and Rizaben Label ), TERNELIN (View Ternelin Review and Ternelin Label ), PHELLOBERIN (View Phelloberin Review and Phelloberin Label ), ENTOMIN (View Entomin Review and Entomin Label ), TIMOPTIC XE (View Timoptic-xe Review and Timoptic-xe Label ).